ARTICLE | Politics & Policy
Senators seek comment on Gilead pricing report
January 22, 2016 2:09 AM UTC
U.S. Senators Ron Wyden (D-Ore.) and Chuck Grassley (R-Iowa) issued an open Sovaldi sofosbuvir and Harvoni ledipasvir/sofosbuvir from Gilead Sciences Inc. (NASDAQ:GILD). Comments are due March 4. ...